Pharmaids Pharmaceuticals Limited (BOM:524572)
42.46
-1.79 (-4.05%)
At close: Jan 23, 2026
Pharmaids Pharmaceuticals Revenue
Pharmaids Pharmaceuticals had revenue of 86.05M INR in the quarter ending September 30, 2025, with 64.24% growth. This brings the company's revenue in the last twelve months to 248.12M, down -1.08% year-over-year. In the fiscal year ending March 31, 2025, Pharmaids Pharmaceuticals had annual revenue of 195.14M with 27.54% growth.
Revenue (ttm)
248.12M
Revenue Growth
-1.08%
P/S Ratio
6.04
Revenue / Employee
8.86M
Employees
28
Market Cap
1.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 195.14M | 42.14M | 27.54% |
| Mar 31, 2024 | 153.00M | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | 39.39M | -46.12M | -53.93% |
| Mar 31, 2021 | 85.51M | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.57B |
| Bal Pharma | 2.95B |
| Parnax Lab | 2.05B |
| Ambalal Sarabhai Enterprises | 1.97B |
| Lactose (India) | 1.37B |
| Astonea Labs | 1.17B |
| Oxygenta Pharmaceutical | 1.12B |
| Aayush Wellness | 1.11B |